Seven Eight Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,697
| Closed | -$2.07M | – | 92 |
|
|
2024
Q3 | $2.07M | Buy |
+24,697
| New | +$1.95M | 0.19% | 176 |
|
|
2024
Q2 | – | Sell |
-11,555
| Closed | -$791K | – | 712 |
|
|
2024
Q1 | $791K | Sell |
11,555
-87,581
| -88% | -$5.63M | 0.08% | 352 |
|
|
2023
Q4 | $5.73M | Buy |
+99,136
| New | +$5.29M | 0.66% | 33 |
|
|
2023
Q3 | – | Sell |
-69,060
| Closed | -$3.74M | – | 600 |
|
|
2023
Q2 | $3.74M | Buy |
+69,060
| New | +$3.61M | 0.62% | 33 |
|
|
2022
Q4 | – | Sell |
-7,326
| Closed | -$284K | – | 427 |
|
|
2022
Q3 | $284K | Buy |
+7,326
| New | +$294K | 0.06% | 391 |
|
|
2022
Q2 | – | Sell |
-103,308
| Closed | -$4.58M | – | 401 |
|
|
2022
Q1 | $4.58M | Buy |
+103,308
| New | +$4.48M | 0.61% | 35 |
|
|
2021
Q4 | – | Sell |
-44,965
| Closed | -$1.95M | – | 478 |
|
|
2021
Q3 | $1.95M | Sell |
44,965
-72,561
| -62% | -$3.21M | 0.19% | 190 |
|
|
2021
Q2 | $5.03M | Buy |
117,526
+60,226
| +105% | +$2.53M | 0.7% | 12 |
|
|
2021
Q1 | $2.06M | Hold |
57,300
| – | – | 0.47% | 60 |
|
|
2020
Q4 | $2.06M | Buy |
57,300
+9,900
| +21% | +$357K | 0.47% | 60 |
|
|
2020
Q3 | $1.81M | Buy |
+47,400
| New | +$1.83M | 0.39% | 45 |
|
|
2019
Q2 | – | Sell |
-178,435
| Closed | -$6.85M | – | 590 |
|
|
2019
Q1 | $6.85M | Buy |
+178,435
| New | +$6.81M | 0.36% | 81 |
|
|
2018
Q3 | – | Sell |
-10,491
| Closed | -$343K | – | 579 |
|
|
2018
Q2 | $343K | Buy |
+10,491
| New | +$316K | 0.02% | 400 |
|
|
2018
Q1 | – | Sell |
-233,591
| Closed | -$5.79M | – | 383 |
|
|
2017
Q4 | $5.79M | Buy |
+233,591
| New | +$6.44M | 0.59% | 41 |
|
|
2017
Q3 | – | Sell |
-28,391
| Closed | -$787K | – | 455 |
|
|
2017
Q2 | $787K | Buy |
+28,391
| New | +$753K | 0.11% | 246 |
|
|
2016
Q3 | – | Sell |
-19,691
| Closed | -$460K | – | 362 |
|
|
2016
Q2 | $460K | Buy |
+19,691
| New | +$426K | 0.16% | 200 |
|
|
2015
Q4 | – | Sell |
-11,791
| Closed | -$193K | – | 557 |
|
|
2015
Q3 | $193K | Buy |
+11,791
| New | +$202K | 0.17% | 198 |
|
|
2014
Q4 | – | Sell |
-20,617
| Closed | -$243K | – | 507 |
|
|
2014
Q3 | $243K | Buy |
+20,617
| New | +$260K | 0.19% | 193 |
|
|
2014
Q1 | – | Sell |
-4,317
| Closed | -$52K | – | 294 |
|
|
2013
Q4 | $52K | Buy |
+4,317
| New | +$51K | 0.06% | 396 |
|
Other funds holding BSX
Seven Eight Capital's BSX Position: Q4 2024 in Review
Seven Eight Capital sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 24,697 shares — an estimated $2.07M sold.
Seven Eight Capital first reported a position in BSX in Q4 2013 and held it in 19 quarters. The position peaked at $6.85M in Q1 2019. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.
- Seven Eight Capital reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
- Seven Eight Capital sold 24,697 Boston Scientific shares in Q4 2024, an estimated $2.07M.
- Seven Eight Capital first reported a position in Boston Scientific in Q4 2013 and held it in 19 quarters.
- Seven Eight Capital's Boston Scientific position peaked at $6.85M in Q1 2019.
- 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.
Based on Seven Eight Capital's 13F filing for Q4 2024.